Evidence map›Paper›PMID 41636965›Full record

ReviewJournal of hematopathology2026

B-cell acute lymphoblastic leukemia following myelodysplastic syndromes: a case report and literature review.

Hanyi Ding, Weiying Feng, Hongqiang Luo, Jing Jin

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Journal of hematopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hanyi DingDepartment of Hematology, Shaoxing People's Hospital, The First Hospital of Shaoxing University, 568 Zhongxingbei Road, Shaoxing, Zhejiang, China.
Weiying FengDepartment of Hematology, Shaoxing People's Hospital, The First Hospital of Shaoxing University, 568 Zhongxingbei Road, Shaoxing, Zhejiang, China.
Hongqiang LuoDepartment of Hematology, Shaoxing People's Hospital, The First Hospital of Shaoxing University, 568 Zhongxingbei Road, Shaoxing, Zhejiang, China.
Jing JinDepartment of Hematology, Shaoxing People's Hospital, The First Hospital of Shaoxing University, 568 Zhongxingbei Road, Shaoxing, Zhejiang, China. 63345498@qq.com.

Funding

Zhejiang Provincial High-Level Health Innovation Talent Training Program No.240150490001/2401644900010001-CXRC202201
6 · The paper itself

Abstract

Myelodysplastic syndromes (MDS) comprise clonal hematopoietic stem cell disorders characterized by heterogeneous clinical manifestations. Approximately 20-30% of MDS cases progress to acute myeloid leukemia, whereas transformation to acute lymphoblastic leukemia (ALL) is extremely rare. In this report, we present the case of a Chinese male patient who presented with MDS-refractory anemia with ringed sideroblasts, which developed into B-cell ALL. During disease transformation, the patient acquired novel gene mutations. By comparing the gene mutations identified at the initial MDS diagnosis with those observed at the time of transformation to ALL, we aim to elucidate the genetic alterations associated with disease progression. Furthermore, we provide a comprehensive review of 60 MDS and MDS/MPN cases reported in the literature so far.

Indexed as

Myelodysplastic SyndromesPrecursor B-Cell Lymphoblastic Leukemia-LymphomaCell Transformation, NeoplasticHumansMaleMutationAcute lymphoblastic leukemiaALLLeukemiaMDSMyelodysplastic syndromes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.